rheumatologyadvisor22h
FDA Drug Approval Decisions Expected in February 2025
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
When Aditya Roy Kapur reflected on his career struggles with back-to-back flops: 'It was a vulnerable time in my life'
Aditya acknowledged that the challenges he faced weren’t just professional but also personal, as they impacted his confidence ...
Pharmabiz4h
In 2024 EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance
EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance: Amsterdam, The Netherlands Saturday, January 18, 2025, 13:00 Hrs [IST] European Me ...